Precipio, Inc. (NASDAQ:PRPO – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $5.85 and traded as high as $6.73. Precipio shares last traded at $6.29, with a volume of 17,946 shares.
Precipio Trading Up 6.6 %
The business has a 50 day moving average price of $5.74 and a 200 day moving average price of $5.85. The company has a market capitalization of $9.89 million, a P/E ratio of -1.89 and a beta of 1.41. The company has a current ratio of 0.73, a quick ratio of 0.59 and a debt-to-equity ratio of 0.03.
Precipio (NASDAQ:PRPO – Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.83) EPS for the quarter. The firm had revenue of $4.44 million during the quarter. Precipio had a negative net margin of 22.90% and a negative return on equity of 39.66%.
Precipio Company Profile
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
Recommended Stories
- Five stocks we like better than Precipio
- What Are Dividend Contenders? Investing in Dividend Contenders
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is the Shanghai Stock Exchange Composite Index?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- 10 Best Airline Stocks to Buy
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.